Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancer

Pathology Research and Practice

Volumn 208, Issue 2, 2012, Pages 104-108

  Petraki, Constantina ^a   Dubinski, William ^b,c   Scorilas, Andreas ^d   Saleh, Carol ^c   Pasic, Maria D ^b   Komborozos, Vassilios ^e   Khalil, Bishoy ^b   Gabril, Manal Y ^f   Streutker, Catherine ^b,c   Diamandis, Eleftherios P ^b   Yousef, George M ^b,c  

^a METROPOLITAN HOSPITAL   (Greece)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF ATHENS   (Greece)

^e EVANGELISMOS HOSPITAL   (Greece)

^f LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Colorectal cancer; Kallikreins; KLK; KLK6; Prognosis

Indexed keywords

KALLIKREIN 6;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL FEATURE; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GREECE; HUMANS; IMMUNOHISTOCHEMISTRY; KALLIKREINS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84856975609     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2011.12.010     Document Type: Article

References (33)

1. Bernett M.J., Blaber S.I., Scarisbrick I.A., Dhanarajan P., Thompson S.M., Blaber M. Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system. J. Biol. Chem. 2002, 277:24562-24570.
2. Clements J.A., Willemsen N.M., Myers S.A., Dong Y. The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers. Crit. Rev. Clin. Lab. Sci. 2004, 41:265-312.
3. Darling M.R., Jackson-Boeters L., Daley T.D., Diamandis E.P. Human kallikrein 6 expression in salivary gland tumors. J. Histochem. Cytochem. 2006, 54:337-342.
4. Diamandis E.P., Scorilas A., Fracchioli S., Van Gramberen M., De Bruijn H., Henrik A., Soosaipillai A., Grass L., Yousef G.M., Stenman U.H., Massobrio M., Van Der Zee A.G., Vergote I., Katsaros D. Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma. J. Clin. Oncol. 2003, 21:1035-1043.
5. Diamandis E.P., Yousef G.M. Human tissue kallikreins: a family of new cancer biomarkers. Clin. Chem. 2002, 48:1198-1205.
6. Diamandis E.P., Yousef G.M., Soosaipillai A.R., Bunting P. Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma. Clin. Biochem. 2000, 33:579-583.
7. Emami N., Diamandis E.P. Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers. Clin. Chem. 2008, 54:1600-1607.
8. Henkhaus R.S., Gerner E.W., Ignatenko N.A. Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells. Biol. Chem. 2008, 389:757-764.
9. Kim J.T., Song E.Y., Chung K.S., Kang M.A., Kim J.W., Kim S.J., Yeom Y.I., Kim J.H., Kim K.H., Lee H.G. Up-regulation and clinical significance of serine protease kallikrein 6 in colon cancer. Cancer 2010.
10. Kim J.T., Song E.Y., Chung K.S., Kang M.A., Kim J.W., Kim S.J., Yeom Y.I., Kim J.H., Kim K.H., Lee H.G. Up-regulation and clinical significance of serine protease kallikrein 6 in colon cancer. Cancer 2011, 117:2608-2619.
11. Liu X.L., Wazer D.E., Watanabe K., Band V. Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression. Cancer Res. 1996, 56:3371-3379.
12. Magklara A., Mellati A.A., Wasney G.A., Little S.P., Sotiropoulou G., Becker G.W., Diamandis E.P. Characterization of the enzymatic activity of human kallikrein 6: autoactivation, substrate specificity, and regulation by inhibitors. Biochem. Biophys. Res. Commun. 2003, 307:948-955.
13. Mavridis K., Scorilas A. Prognostic value and biological role of the kallikrein-related peptidases in human malignancies. Future Oncol. 2010, 6:269-285.
14. Ogawa K., Utsunomiya T., Mimori K., Tanaka F., Inoue H., Nagahara H., Murayama S., Mori M. Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer. Clin. Cancer Res. 2005, 11:2889-2893.
15. Pampalakis G., Kurlender L., Diamandis E.P., Sotiropoulou G. Cloning and characterization of novel isoforms of the human kallikrein 6 gene. Biochem. Biophys. Res. Commun. 2004, 320:54-61.
16. Pampalakis G., Prosnikli E., Agalioti T., Vlahou A., Zoumpourlis V., Sotiropoulou G. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition. Cancer Res. 2009, 69:3779-3787.
17. Pampalakis G., Sotiropoulou G. Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer. Biol. Chem. 2006, 387:773-782.
18. Petraki C.D., Karavana V.N., Revelos K.I., Luo L.Y., Diamandis E.P. Immunohistochemical localization of human kallikreins 6 and 10 in pancreatic islets. Histochem. J. 2002, 34:313-322.
19. Petraki C.D., Papanastasiou P.A., Karavana V.N., Diamandis E.P. Cellular distribution of human tissue kallikreins: immunohistochemical localization. Biol. Chem. 2006, 387:653-663.
20. Schultz R.M., Liebman M.N. Structure-function relationship in protein families. Textbook of Biochemistry with Clinical Correlations 1997, 1-2. Wiley-liss Inc., New York. T.M. Devlin (Ed.).
21. Stephan C., Jung K., Nakamura T., Yousef G.M., Kristiansen G., Diamandis E.P. Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancer. Int. J. Urol. 2006, 13:238-243.
22. Tan O.L., Whitbread A.K., Clements J.A., Dong Y. Kallikrein-related peptidase (KLK) family mRNA variants and protein isoforms in hormone-related cancers: do they have a function?. Biol. Chem. 2006, 387:697-705.
23. White N.M., Bui A., Mejia-Guerrero S., Chao J., Soosaipillai A., Youssef Y., Mankaruos M., Honey R.J., Stewart R., Pace K.T., Sugar L., Diamandis E.P., Dore J., Yousef G.M. Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs. Biol. Chem. 2010, 391:411-423.
24. Yousef G.M., Borgono C.A., White N.M., Robb J.D., Michael I.P., Oikonomopoulou K., Khan S., Diamandis E.P. In silico analysis of the human kallikrein gene 6. Tumour Biol. 2004, 25:282-289.
25. Yousef G.M., Diamandis E.P. The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr. Rev. 2001, 22:184-204.
26. Yousef G.M., Diamandis E.P. Expanded human tissue kallikrein family - a novel panel of cancer biomarkers. Tumour Biol. 2002, 23:185-192.
27. Yousef G.M., Diamandis E.P. An overview of the kallikrein gene families in humans and other species: emerging candidate tumour markers. Clin. Biochem. 2003, 36:443-452.
28. Yousef G.M., Diamandis E.P. The human kallikrein gene family: new biomarkers for ovarian cancer. Cancer Treat. Res. 2009, 149:165-187.
29. Yousef G.M., Elliott M.B., Kopolovic A.D., Serry E., Diamandis E.P. Sequence and evolutionary analysis of the human trypsin subfamily of serine peptidases. Biochim. Biophys. Acta 2004, 1698:77-86.
30. Yousef G.M., Luo L.Y., Scherer S.W., Sotiropoulou G., Diamandis E.P. Molecular characterization of zyme/protease M/neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease. Genomics 1999, 62:251-259.
31. Yousef G.M., Obiezu C.V., Luo L.Y., Magklara A., Borgono C.A., Kishi T., Memari N., Michael P., Sidiropoulos M., Kurlender L., Economopolou K., Kapadia C., Komatsu N., Petraki C., Elliott M., Scorilas A., Katsaros D., Levesque M.A., Diamandis E.P. Human tissue kallikreins: from gene structure to function and clinical applications. Adv. Clin. Chem. 2005, 39:11-79.
32. Yousef G.M., Polymeris M.E., Grass L., Soosaipillai A., Chan P.C., Scorilas A., Borgono C., Harbeck N., Schmalfeldt B., Dorn J., Schmitt M., Diamandis E.P. Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer. Cancer Res. 2003, 63:3958-3965.
33. Yousef G.M., Yacoub G.M., Polymeris M.E., Popalis C., Soosaipillai A., Diamandis E.P. Kallikrein gene downregulation in breast cancer. Br. J. Cancer 2004, 90:167-172.